CollPlant Biotechnologies Statistics
Total Valuation
CLGN has a market cap or net worth of $7.51 million. The enterprise value is $7.61 million.
| Market Cap | 7.51M |
| Enterprise Value | 7.61M |
Important Dates
The next estimated earnings date is Wednesday, November 25, 2026, before market open.
| Earnings Date | Nov 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CLGN has 1.89 million shares outstanding. The number of shares has increased by 16.22% in one year.
| Current Share Class | 1.89M |
| Shares Outstanding | 1.89M |
| Shares Change (YoY) | +16.22% |
| Shares Change (QoQ) | +4.94% |
| Owned by Insiders (%) | 40.14% |
| Owned by Institutions (%) | 9.61% |
| Float | 1.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 23.61 |
| Forward PS | 7.22 |
| PB Ratio | 1.95 |
| P/TBV Ratio | 2.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 23.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.90.
| Current Ratio | 1.57 |
| Quick Ratio | 1.19 |
| Debt / Equity | 0.90 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -165.40 |
Financial Efficiency
Return on equity (ROE) is -161.98% and return on invested capital (ROIC) is -73.36%.
| Return on Equity (ROE) | -161.98% |
| Return on Assets (ROA) | -62.95% |
| Return on Invested Capital (ROIC) | -73.36% |
| Return on Capital Employed (ROCE) | -263.32% |
| Weighted Average Cost of Capital (WACC) | 6.02% |
| Revenue Per Employee | $8,154 |
| Profits Per Employee | -$320,846 |
| Employee Count | 39 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 2.45 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.87% in the last 52 weeks. The beta is 0.57, so CLGN's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | -81.87% |
| 50-Day Moving Average | 3.80 |
| 200-Day Moving Average | 4.84 |
| Relative Strength Index (RSI) | 51.80 |
| Average Volume (20 Days) | 47,193 |
Short Selling Information
The latest short interest is 52,732, so 2.12% of the outstanding shares have been sold short.
| Short Interest | 52,732 |
| Short Previous Month | 42,221 |
| Short % of Shares Out | 2.12% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.74 |
Income Statement
In the last 12 months, CLGN had revenue of $318,000 and -$12.51 million in losses. Loss per share was -$9.32.
| Revenue | 318,000 |
| Gross Profit | -1.02M |
| Operating Income | -12.41M |
| Pretax Income | -12.51M |
| Net Income | -12.51M |
| EBITDA | -11.56M |
| EBIT | -12.41M |
| Loss Per Share | -$9.32 |
Balance Sheet
The company has $2.56 million in cash and $2.66 million in debt, with a net cash position of -$101,000 or -$0.05 per share.
| Cash & Cash Equivalents | 2.56M |
| Total Debt | 2.66M |
| Net Cash | -101,000 |
| Net Cash Per Share | -$0.05 |
| Equity (Book Value) | 2.95M |
| Book Value Per Share | 2.04 |
| Working Capital | 1.41M |
Cash Flow
In the last 12 months, operating cash flow was -$11.19 million and capital expenditures -$91,000, giving a free cash flow of -$11.29 million.
| Operating Cash Flow | -11.19M |
| Capital Expenditures | -91,000 |
| Depreciation & Amortization | 846,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -11.29M |
| FCF Per Share | -$5.97 |
Margins
| Gross Margin | n/a |
| Operating Margin | -3,900.94% |
| Pretax Margin | -3,934.91% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CLGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -16.22% |
| Shareholder Yield | -16.22% |
| Earnings Yield | -234.79% |
| FCF Yield | -150.34% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 7.45% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on September 4, 2026. It was a reverse split with a ratio of 1:10.
| Last Split Date | Sep 4, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
CLGN has an Altman Z-Score of -28.14 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -28.14 |
| Piotroski F-Score | 1 |